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Abstract
Background: The validity of Doppler echocardiographic (DE) measurement of systolic pulmonary artery pressure (sPAP) has
been questioned. Recent studies suggest that mean pulmonary artery pressure (mPAP) might reflect more accurately the
invasive pressures.
Methodology/Principal Findings: 241 patients were prospectively studied to evaluate the diagnostic accuracy of mPAP for
the diagnosis of PH. Right heart catheterization (RHC) and DE were performed in 164 patients mainly for preoperative
evaluation of heart valve dysfunction. The correlation between DE and RHC was better when mPAP (r=0.93) and not sPAP
(r=0.81) was assessed. Bland-Altman analysis revealed a smaller variation of mPAP than sPAP. The following ROC analysis
identified that a mPAP$25.5 mmHg is useful for the diagnosis of PH. This value was validated in an independent cohort of
patients (n=50) with the suspicion of chronic-thromboembolic pulmonary hypertension. The calculated diagnostic
accuracy was 98%, based on excellent sensitivity of 98% and specificity of 100%. The corresponding positive and negative
predictive values were 100%, respectively 88%.
Conclusion: mPAP has been found to be highly accurate for the initial diagnosis of PH. A cut-off value of 25.5 mmHg might
be helpful to avoid unnecessary RHC and select patients in whom RHC might be beneficial.
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Introduction
Pulmonary hypertension (PH) is associated with restricted flow
through the pulmonary circulation, increased pulmonary vascular
resistance and right heart failure [1]. Since the last decades PH has
been identified as a devastating disease with a high mortality in
dependence on the clinical classifications [2,3]. Early diagnosis is
essential to identify patients at high risk, treat the PH and modify
the etiologic substrate. PH has been defined as an elevation of
mean pulmonary artery pressure (mPAP)$25 mmHg in right
heart catheterization (RHC) [1,4]. When PH is suspected in
patients based on the history, risk factor assessment, and physical
examination, an echocardiogram has been addressed as the next
appropriate study [4]. The Doppler echocardiogram (DE) can
simultaneously provide an estimate of right ventricular systolic
pressure (RVSP), functional and morphologic cardiac sequelae of
PH, and identification of possible cardiac causes of PH or the
presented clinical symptoms. The need for further invasive
diagnostics is often triggered by the DE assessment of the peak
systolic PAP (sPAP). But the reported accuracy of sPAP deter-
mination by DE is controversial. While initial comparisons
between DE and RHC revealed an acceptable correlation [5,6],
recent studies questioned the diagnostic value of DE in PH [7–9]. In
the present studywe aimed to determine whether echocardiographic
assessment of mPAP is more accurate than sPAP for initial diagnosis
of PH and estimation of real pulmonary artery pressure.
Methods
The study was performed in accordance with the STARD
criteria to improve the quality of diagnostic accuracy [10]. The
calculated diagnostic accuracy was validated in an independent
cohort.
Ethics Statement
The study complies with the Declaration of Helsinki. All
participants gave their written informed consent and the Ethics
Committee of the University of Cologne approved the conduct of
this study.
Subjects
Consecutive patients referred to the Cardiology Department of
the University of Cologne were included in this prospective study
from December 2008 to June 2010. All patients had a clinical
indication for RHC due to heart failure, aortic or mitral valve
dysfunction or the suspicion of PH. All patients in the validation
group had a history of pulmonary embolism and the clinical
suspicion of PH.
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e15670Right Heart Catheterization
RHC was performed without sedation at rest in the cardiac
catheter laboratory of the Cardiology Department of the
University of Cologne. End-expiratory pressure measurements
were taken from the right atrium, right ventricle, pulmonary artery
and pulmonary capillary.
Transthoracic echocardiography
Comprehensive two-dimensional echocardiography was per-
formed in all patients within 120 minutes before right heart
catheterization using a Phillips iE33 ultrasound device equipped
with a standard transducer operating at 1–5 MHz without using
saline contrast. The echocardiography was performed by three
different cardiologists. In each patient only one cardiologist
performed the examination, randomly. Multiple views were
recorded to identify optimal view for analysis as recommended
in actual guidelines [11–13]. The right atrial pressure (RAP) was
estimated by evaluating the inferior vena cava (IVC) diameter
(IVCd) and change with respiration [14,15]: when IVCd was less
than 20 mm and the collapsibility greater than 50% RAP was
estimated to be 5 mmHg versus 10 mmHg when the collapsibility
was less than 50%. When the IVCd was greater than 20 mm RAP
was estimated to be 15 mmHg when the collapsibility was greater
than 50% and to be 20 mmHg when the collapsibility was less
than 50%.
Additionally to the mean gradient estimation, mPAP was calculated
using the Chemla formula (mPAP=0.616sPAP +2 mmHg) and the
Syyed formula (mPAP=0.656sPAP +0.55 mmHg) [16–18].
Continuous wave Doppler was used to determine the peak
velocity of the tricuspid regurgitant (TR) jet at end-expiration.
Patients were excluded when TR jet was not available. The
highest TR velocity was measured and traced to obtain the peak
and mean systolic right-ventricular-right-atrial (RV-RA) gradient.
The mean gradient was calculated by tracing the TR time-
velocity integral plus RAP [19]. The sPAP was calculated using
the highest RV-RA gradient plus estimated RA pressure. The
mPAP was calculated as mean RV-RA pressure plus estimated
RA pressure. The quality of continuous Doppler envelope was
graded by a blinded cardiologist from 1 (excellent visualization
with full spade shaped Doppler envelope with exactly detectable
peak) to 5 (poorly visualization of Doppler signal and peak
velocity).
The potential confounding factors in echocardiographic right
heart assessment like right heart dimensions, the presence of atrial
fibrillation or severe tricuspid regurgitation were documented, but
not corrected in any direction. In these cases the measurements
were performed like in all other patients.
The right ventricular function was estimated by calculating the
tricuspid annular plane systolic excursion (TAPSE). Left ventric-
ular ejection fraction (LVEF) was estimated by the Simpson’s rule
in the four and two chamber views.
Statistics
All variables were tested for normal distribution with the
Kolmogorov-Smirnov test. Continuous variables are expressed as
means 6 standard deviation (SD). Comparison of 2 means was
performed with the t test for normally distributed variables and the
Mann-Whitney U test for non-Gaussian variables. Chi-square test
was used for nonparametric comparisons. For diagnostic utility
calculations receiver operating characteristic (ROC) curves were
used. Results are expressed in terms of area under the curve (AUC)
and 95% CI for this area. Sensitivity and specificity were estimated
with ROC curves. Accuracy, positive predictive value (PPV) and
negative predictive value (NPV) were calculated accordingly.
Pressure comparisons were done using analysis described by
Bland-Altman with predefined accuracy as 95% limits of
agreement 62xSD [20]. All statistical tests were 2-tailed, and
p,0.05 was considered statistically significant. Statistical analysis
was performed using SPSS 18 (SPSS GmbH Software – IBM
Company, Munich, Germany).
Results
Baseline characteristics
191 consecutive patients with an indication for RHC were
eligible for the study. 7 patients refused to participate in the study,
Table 1. Characteristics of 164 patients and indications for
RHC.
Age 63.7615.5
Men (%) 88 (54)
BMI 26.665.5
Echocardiography
Left atrial diameter, mm 43.6610.3
Left ventricular enddiastolic diameter, mm 51.7611.2
Left ventricular ejection fraction, % 54.9614.5
Enddiastolic interventricular septum, mm 11.262.3
TAPSE, mm 18.164.6
Right mid-ventricular diameter, mm 36.467.5
Right ventricular diameter-long axis, mm 60.74614.8
mPAP, mean gradient method (mmHg) 37.1612.2
mPAP, calculated with Chemla formula (mmHg) 37.9612.5
mPAP, calculated with Syyed formula (mmHg) 37.5611.8
Medical history
Hypertension (%) 87 (53)
Coronary heart disease (%) 65 (40)
Diabetes (%) 27 (16)
Heart failure (%) 95 (58)
Ischemic cardiomyopathy (%) 32 (20)
Dilated cardiomyopathy (%) 41 (25)
Chronic obstructive pulmonary disease (%) 11 (7)
Atrial fibrillation (%) 42 (26)
NYHA functional class
I (%) 8 (5)
II (%) 61 (37)
III (%) 83 (51)
IV (%) 12 (7)
Indication for RHC
Aortic valve evaluation (%) 41 (25)
- Aortic valve stenosis (%) 37 (23)
- Aortic valve regurgitation (%) 4 (2)
Mitral valve evaluation (%) 74 (45)
- Mitral valve stenosis (%) 11 (7)
- Mitral valve regurgitation (%) 63 (38)
Heart failure evaluation (%) 49 (30)
- Evaluation for heart transplantation (%) 11 (7)
BMI indicates body mass index (kg/m
2), RHC indicates right heart
catheterization.
doi:10.1371/journal.pone.0015670.t001
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predefined time schedule and 11 in patients an analyzable TR jet
was not available. Data from a total of 164 patients were available
for final analysis. The baseline characteristics of the study
participants are displayed in Table 1. The majority of the patients
underwent RHC for invasive evaluation of the aortic (n=74) or
mitral (n=49) valve dysfunction. In 41 patients RHC was
performed for heart failure assessment, in 11 of these patients
for scheduling for heart transplantation.
Correlation of invasive versus echocardiographic sPAP,
mPAP and RAP
In all patients echocardiographic evaluation of mPAP and
sPAP were performed. The comparison of invasive versus
echocardiographic mPAP revealed a better correlation than the
sPAP in RHC versus echocardiography (Figure 1). The correlation
coefficient for DE and invasive sPAP was 0.81 (p,0.001)
compared to 0.93 for mPAP in DE versus RHC (p,0.001). Both,
echocardiographic sPAP and mPAP calculations were influenced
by the estimated RAP. The correlation of DE and invasive RAP
was weaker than seen for mPAP and sPAP (r=0.67; p,0.001).
Better Doppler signal quality improved the documented correla-
tions (Figure 1).
Using Bland-Altman analysis, the bias for the echocardiograph-
ic estimates of sPAP was -4.1 mmHg with 95% limits of agreement
ranging from +23 mmHg to 229 mmHg (Figure 2A). In contrast
bias for the mPAP measurements was 0.3 mmHg with 95% limits
of agreement ranging from +12 to 212 mmHg (Figure 2B).
Figure 1. DE versus RHC correlations. DE mPAP (B) was better correlated with RHC than sPAP (A). Dotted lines mark virtual best correlation of 1
and solid lines mark the real correlation. r indicates the correlation coefficient, sPAP indicates systolic pulmonary artery pressure.
doi:10.1371/journal.pone.0015670.g001
Figure 2. Bland-Altman plot of DE estimates of PA and RHC pressures for sPAP (A) and mPAP (B). Smaller bias and limits of agreement
present in mPAP measurements compared to sPAP measurements.
doi:10.1371/journal.pone.0015670.g002
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explain smaller variations of mPAP. To rule out this fact the
relative variation of mPAP and sPAP in DE vs. RHC were
calculated. But even the relative differences between DE and RHC
were larger for sPAP than mPAP indicating a better correlation of
DE mPAP and RHC vs. DE sPAP and RHC (Figure 3A).
Correlation and Bland-Altman analysis identified an excellent
correlation of echocardiographic mPAP and RHC between 20 and
40 mmHg (Figure 1). We identified this range to be important for
the diagnosis of PH. Therefore using the ROC analysis we tested
the usefulness of echocardiographic mPAP for the diagnosis of PH.
For this calculation PH was defined as invasive mPAP$25 mmHg
[21]. The ROC analysis revealed a useful sensitivity and specificity
of mPAP for diagnosis of PH with DE, reflected by an area under
curve (AUC) of 0.95 (95 CI; 0.914–0.983; p,0.001; Figure 3B). A
cut-off value of mPAP$25.5 mmHg could detect PH with a
Figure 3. Analysis of relative differences and ROC analysis of mPAP for diagnosis of PH. A, the relative positive and negative deviation
between DE and RHC were larger for sPAP than mPAP. B, ROC analysis reveal an excellent diagnostic accuracy of mPAP for the diagnosis of PH with
an area under the curve (AUC) of 0.95.
doi:10.1371/journal.pone.0015670.g003
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likelihood ratios (LR) were 5.76 for positive LR and 0.18 for
negative LR (Table 2).
Validation of mPAP for the Diagnosis of PH
The diagnostic accuracy of mPAP for the detection of patients
with PH was tested in an independent cohort of patients. 50
consecutive patients who were referred to the Cardiology
Department for invasive RHC with a history of pulmonary
embolism and the clinical suspicion of chronic-thromboembolic
PH were included. The demographics and invasive vs. DE
pressures are displayed in table 3. There were no exclusions. Using
the DE cut-off value of 25.5 mmHg 42 patients were identified to
have a PH (Figure 4). RHC confirmed in all 42 patients the
diagnosis of PH. In 8 patients DE suggested that a PH could be
excluded. In one of these patients the result was false negative. The
calculated diagnostic accuracy was 98%, based on excellent
sensitivity of 98% and specificity of 100%. The corresponding
positive and negative predictive values were 100% and 88%.
Discussion
We examined the diagnostic accuracy of mPAP for the
diagnosis of PH. We applied DE assessment in a large number
of patients undergoing RHC for several reasons. Comparison
analysis revealed that DE mPAP reflects more precisely the
invasive pressures than DE sPAP does. Based on this observation
the performed ROC analysis displayed that mPAP is useful for
diagnosis of PH. The accuracy of mPAP for PH was validated in
an independent high-risk cohort of patients with the suspicion of
PH. An excellent sensitivity of 98%, specificity of 100% and
accuracy of 98% of this diagnostic tool could be confirmed. Only
in one of forty-three patients with borderline PH DE was false
negative and in none of the patients false positive.
Despite of promising therapeutic options emerged in the last
decades, mortality remains high among patients with PH [22,23].
Early diagnosis of PH may change its detrimental character and its
annual mortality rate of 15% [24]. But still the diagnosis of PH is
challenging. The invasive assessment of the right heart and
pulmonary arteries has been established as the gold standard in the
diagnosis of PH [21]. It helps to differentiate pre- and postcapillary
PH. Due to its invasive character RHC is not useful as a routine
screening method. Echocardiography is a widely available and
accepted noninvasive diagnostic instrument for assessment of right
heart function and dimension [13,25–29]. Initial studies reported a
good correlation between DE and RHC [5,6].
But recent DE studies questioned the diagnostic value of DE for
PH assessment displaying a large variation of sPAP [7–9]. In a
well-designed study Fisher and Colleagues assessed the usability of
DE for evaluation of sPAP and found despite a good correlation a
wide and inacceptable discrepancies between DE and RHC in
Bland-Altman analysis [7]. Our results are in agreement with
previous findings. Therefore DE sPAP may not useful for the
diagnosis and estimation of pulmonary artery pressure.
It is of clinical interest to identify patients with PH early and in a
feasible and economic way. We identified DE as a helpful tool for
the diagnosis of PH when mPAP and not sPAP is used. Our results
concerning the correlation of mPAP in DE vs. RHC are supported
by recent studies [30,31]. Aduen and coworkers identified
echocardiographic mPAP as a valuable parameter for the assess-
ment of pulmonary artery pressure and confirmed that the method
used in our study of mean gradient estimation is equally applicable
to the Chemla formula and the Syyed formula [16–18,30,31].
In 43 of 50 patients with the suspicion of PH the diagnosis of
PH could be confirmed. Of these patients almost one third had
mild, one third moderate and one third severe PH. Hence,
echocardiographic mPAP may be suitable in a wide range of PH
severity. Especially the detection of PH in mildly symptomatic or
mildly elevated mPAP is crucial. Echocardiographic mPAP may
be a helpful screening tool in these patients.
Table 2. Diagnostic value of different mPAP cut-offs for
diagnosis of PH.
mPAP$
(mmHg) Sensitivity Specificity Positive LR Negative LR
23.5 96 68 2.99 0.33
24.5 95 80 4.75 0.21
25.5 92 84 5.76 0.18
26.5 90 84 5.62 0.18
27.5 87 88 7.26 0.14
LR indicates likelihood ratio.
doi:10.1371/journal.pone.0015670.t002
Table 3. Demographics, RHC and DE measurements of the
validation group (n=50).
Age 66.9614.5
Men (%) 17 (34)
BMI 27.165.1
WHO functional class
I (%) 7 (14)
II (%) 13 (26)
III (%) 26 (52)
IV (%) 4 (8)
Invasive testing
sPAP, mmHg (DE) 63.6623.6 (62.3625.7)
mPAP, mmHg (DE) 39.5614.9 (40.3614.4)
mPAP 25–36 mmHg, mild PH (%) 17/43 (40)
mPAP 37–49 mmHg, moderate PH (%) 14/43 (33)
mPAP$50 mmHg, severe PH (%) 12/43 (28)
PCWP, mmHg 9.964.4
PVR, dynesXsecXcm
25 5986143
SVR, dynesXsecXcm
25 12306317
Cardiac output (L/min) 3.661.2
PA SO2 (%) 65611.3
Aorta SO2 (%) 9464.9
Final Dana Point classification of PH
1. Pulmonary arterial hypertension (%) 2/43 (5)
2. PH due to left heart failure (%) 7/43 (16)
3. PH due to lung diseases (%) 1/43 (2)
4. Chronic thromboembolic hypertension (%) 29/43 (67)
5. PH with unclear and/or multifactorial
mechanisms (%)
4/43 (9)
BMI indicates body mass index (kg/m
2), RHC indicates right heart
catheterization, PCWP indicates pulmonary capillary wedge pressure, PVR
indicates pulmonary vascular resistance. SVR indicates systemic vascular
resistance, PA SO2 indicates pulmonary artery oxygen saturation, aorta SO2
indicates aortic oxygen saturation.
doi:10.1371/journal.pone.0015670.t003
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measurement as accurate for diagnosis of PH. mPAP measure-
ment may prevent unnecessary RHC and identify patients at high
risk for PH.
Study limitations
This study is limited by its focus on a single center’s experience
and the limited sample size of the validation group. In almost 6%
of the patients a TR jet was not analyzable. Saline contrast may
increase the rate on available TR jet signals. The estimation of
RAP is generally challenging as in our study. But despite the large
variation in RAP the calculated accuracy of mPAP was excellent,
suggesting that TR signal alone reflects accurately the PAP.
RHC and DE were not performed simultaneously. While during
Swan-Ganz catheterization simultaneous measurements may be
suitable, it’s a technical challenge performing echocardiography in
the catheter lab during RHC.
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